Human Papillomavirus Vaccination Among Adults Aged 18−26, 2013−2018

A new NCHS report describes trends in self-reported HPV vaccination initiation and completion by selected demographic characteristics among adults aged 18−26.

• Among adults aged 18−26, the percentage who ever received one or more doses of human papillomavirus (HPV) vaccine increased from 22.1% in 2013 to 39.9% in 2018.
• The percentage of adults aged 18−26 who received the recommended number of doses of HPV vaccine increased from 13.8% in 2013 to 21.5% in 2018.
• In 2018, non-Hispanic white adults were more likely than Hispanic adults to have ever received one or more doses of HPV vaccine.
• Among adults aged 18−26 who ever received one or more doses of HPV vaccine, the majority received the first dose between the ages of 13 and 17 years.